Werner Schaefer
Member of the Supervisory Board
Curetis
Germany
Biography
Dr. Werner Schaefer is Member of the Supervisory Board of Curetis BV. He is a specialist in the in-vitro diagnostics industry. He has nearly 30 years of management experience in in-vitro diagnostics, holding various international management positions throughout his career – including general management, marketing and R&D, at major companies comprising Behringwerke/Hoechst, Abbott, Boehringer Mannheim and Roche Diagnostics. At Boehringer and Roche, he led the laboratory systems business unit and he served also as a member of the executive board of Roche Diagnostics GmbH until 2001. Since then, he has worked as a consultant and serves on various executive boards and supervisory boards in 173 highly specialized diagnostics and medical technology companies. He was a member of the supervisory board of BRAHMS AG (2002 to 2009, sold to Thermo Fisher) mtm laboratories AG (2003 to 2011, sold to Roche), Vivacta Limited (2006 to 2012, sold to Novartis), Signature AG (2012-2013), Genomatix Software GmbH (2011 to 2013) and Cognoptix Inc. (2009 to 2014). He currently serves as a member of the advisory board of Human GmbH (since 2005), as the chairman of the board of directors of ProteoMediX AG (since 2012) and as Vice- Chairman of Curetis AG (since 2014). Dr. Schaefer has a PhD in Chemistry from the Philipps University Marburg. He is also Chairman of the Nominating Committee of the Company.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
